Broken String Biosciences

Our technology platform, INDUCE-seq®, detects and quantifies on- and off-targets supporting the development of safer cell and gene therapies.

[Broken String Biosciences @BrokenStringBio]

INDUCE-seq™ is a game changing #technology for development of advanced #therapies, but what is it?

Watch this video to learn how the platform precisely characterises breaks in the #genome, to inform the development of cutting edge therapeutics that are safer by design!🧪

[Broken String Biosciences @BrokenStringBio]

By bringing INDUCE-seq® in-house, researchers gain faster insights, regulatory confidence, and real-time guide selection—a game-changer for gene editing safety.
Enrollment is limited—apply here: https://t.co/ubdbxwSQxx
#GeneEditing #Biotech #CRISPR

[Broken String Biosciences @BrokenStringBio]

We’re thrilled to launch the Catalyst program, our Early Access initiative that brings INDUCE-seq® directly into gene editing labs. Now, therapy developers can detect on- and off-target effects in days instead of months—accelerating development while ensuring safety.

[Chesterford Research Park @ChesterfordRP]

Great to see Park-based @BrokenStringBio highlighted in the @Clarivate 'Companies to Watch: Next Generation Gene Editing' report.

You can download the full report here - https://t.co/5nueiedfnu

[Broken String Biosciences @BrokenStringBio]

This recognition inspires us to continue delivering impactful solutions for the next generation of genomic advancements. Read the full article here: https://t.co/CBE2vYmxJ6

[Broken String Biosciences @BrokenStringBio]

We are thrilled to be recognized for our role in shaping the future of genomic medicine by @pharmavoice. Our cutting-edge technologies provide vital insights for therapy developers, ensuring safety, efficacy, and scalability in the ever-evolving gene-editing landscape.

[Broken String Biosciences @BrokenStringBio]

Read the full article here: https://t.co/CBE2vYmxJ6

[Broken String Biosciences @BrokenStringBio]

Being recognized as a key player in this prestigious list underscores our commitment to redefining genomic safety and shaping the future of cell and gene therapies.

[Broken String Biosciences @BrokenStringBio]

We're thrilled to be featured in Clarivate’s Companies to Watch: Next Generation Gene Editing 2024 report!
https://t.co/LzjjcR0YTf

[Broken String Biosciences @BrokenStringBio]

This coming week, our Director of Alliance Management and CCO will be attending the Cell & Gene Meeting on the Mesa in Phoenix, AZ, from October 7-9, 2024! #

We’re excited to engage in meaningful discussions & explore collaboration opportunities! See you there! #CGMESA24

[Broken String Biosciences @BrokenStringBio]

ICYMI, our Co-founder and CSO, Simon Reed, Ph.D. discusses the current challenges in off-target gene editing and explores what the future holds for safer, more effective therapies.

To watch the webinar on-demand, you may register here: https://t.co/kn1Gjh8urC #GeneEditing

[HealthInvestor UK @HealthInvestor]

Broken String Biosciences: Laurence Reid and Brad Crutchfield https://t.co/UV2XDih2te #healthcare @BrokenStringBio @laurence_reid @Regeneron @ThirdRockV @Alnylam @10xGenomics @QIAGEN @illumina @BioRad

[Chesterford Research Park @ChesterfordRP]

Park-based @BrokenStringBio has strengthened its Board with two new appointments - Laurence Reid, as Chairman, and Brad Crutchfield as Non-Executive Director.

Full story - https://t.co/hxX7mUwsvq

[Zyme Communications @ZymeComms]

Today @BrokenStringBio announced the appointments of Laurence Reid, as Chairman, and Brad Crutchfield as Non-Executive Director of its Board of Directors.

Read more: https://t.co/Nz8bTS8mLO

#PressRelease #CellandGene

[Broken String Biosciences @BrokenStringBio]

Their combined expertise in biotech and life sciences will be crucial as we continue to advance INDUCE-seq and drive growth in the cell and gene therapy industry. Read the full announcement here:

https://t.co/V8qxEKbs1A

[Broken String Biosciences @BrokenStringBio]

Exciting News! We’re delighted to welcome Laurence Reid, Ph.D. as Chairman and Brad Crutchfield as Non-Executive Director to our Board of Directors.

[Broken String Biosciences @BrokenStringBio]

If you are looking for a highly sensitive assay for off-target detection in your gene-edited cell or gene therapy programs, simply email us on [email protected].

[Broken String Biosciences @BrokenStringBio]

INDUCE-seq® can identify DNA double strand breaks without the need for DNA amplification, thus greatly increasing sensitivity and signal to noise ratio.

[Broken String Biosciences @BrokenStringBio]

If you are looking for a highly sensitive assay for off-target detection in your gene-edited cell or gene therapy programs, simply message us at [email protected].

[Impact Newswire @ImpactNewswire]

Broken String Biosciences Appoints Steve Becker as Chief Commercial Officer https://t.co/yJu59SrPis @BrokenStringBio

[Broken String Biosciences @BrokenStringBio]

Steve's leadership will be pivotal as we enhance our offerings in the cell and gene therapy market, ensuring transformative treatments become a safe reality for patients worldwide. Read more here: https://t.co/ul5E0DSU1E

[Broken String Biosciences @BrokenStringBio]

We are thrilled to welcome Steve Becker as our Chief Commercial Officer. With over 30 years of experience in the global life sciences industry and a stellar track record, Steve will spearhead the commercialization of our pioneering DNA break-mapping platform, INDUCE-seq®.